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Valproic	 a 
 
cid
	 
 (VPA),  
 
a	 d 
 
rug
	
 
 
used  
 
in
	
 
 
the
	
 
 
treatment  
 
of
	
 
 
neurological	
 
 disorders,	
 
 has	
 
 been
 
 
	
Original	article 
 	
shown	 
 
to	 
 
have	 
 
cytotoxic	 
 
effects	 
 
on	 
 
cancer	 
 
cells	 
 
through
	
 
 
different	 
 
mechanisms.	
 
 Telomerase,	 
 
a 
 	
ribonucleoprotein	 
 
reverse	 
 
transcriptase,	 
 
is	 
 
responsible	 
 
for	
 
 elongation	 
 
of	 
 
the	 
 
telomere	 
 
and	 
 
is	 
 
activated	 	Article	history:	 in	 
 
cancers.	 
 
A 
 	
relation	
 
 between
	
 
 
telomerase	 
 
activity 
 	
and	 
 
resistance 
 	
to	 
 
apoptosis 
 	
has 
 	
been	 
 
established. 
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 This	s 
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focused	on
	
 
 
probable 
 
effects	of 
 	
 
 
VPA	on	MCF
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cer
	
 
 
cells.	 
 
In	 
 
particular,	 
 
we	 
 
investigated	
 
 VPA	
 
 Accepted:	May	21,	2015	 effects	on	viabili
 
 ty,	apoptosis 
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elomerase	activity.	 
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Introduction Telomerase  	 enzyme  is  	 activated  in  more  than
Breast 	cancer is 	the 	most common malignancy and 90% of	 cancers	 including	 breast cancer	 whereas	 it 
the  leading  cause  of  death  in  women,  	worldwide.  It  is  has	 negative or	 very	 weak	 activity	 in	 the most 
gradually	 increasing and	 brings economic	 burden	 to	 somatic	 cells	 (5).	 Telomerase,	 a	 cellular	 reverse	
patients (1).	 transcriptase, protects	 the ends	 of	 chromosomes 
Valproic	 acid	 (VPA,	 2‐	 pentatonic	 propyl acid),	 a (telomeres).	 Telomeres	 are	 specialized	 structures	 at 
drug	 used	 in	 the	 treatment	 of	 neurological disorders,	 the	 ends	 of	 eukaryotic chromosomes	 that	 normally	
has	 anti‐cancer	 effects	 through	 inhibition of	 histone	 shorten	 during	 each	 cell	 division	 and eventually	
deacetylase	 enzymes	 (HDACi)	 (2).	 VPA	 inhibits	 both cause	 aging	 and	 cell	 death.	 The	 loss	 of	 telomere	
class	 I	 and	 class	 II	 of histon	 deacetylase	 enzymes	 via	 length	 is	 inhibited	 by telomerase	 in	 cancer	 cells	 (6).
hyperacetylation	 of	 histon	 H3	 and	 H4.	 HDACi, Telomerase	 is	 a	 ribonucleoprotein	 complex	 with	 a 
through	 modifying	 chromatin	 structure	 and	 making catalytic	 subunit	 (hTERT)	 and	 an	 RNA	 component 
dynamic	 changes	 in	 the	 nucleosomal	 packaging of	 (hTR)	 as a template	 to	 add	 telomeric	 repeats 
DNA,  play  an  important  	 role  in  	 regulation  of  	 gene (TTAGGG)	to	the	3'	ends	of 	chromosomes	 (7).	Studies	
expression	 (3).	 Studies	 have	 shown	 that inhibitors	 of	 show 	that the level of 	hTERT 	expression in cells 	was 
histone	 deacetylase	 exert their	 effects	 via inhibition associated with	 the	 degree of	 telomerase	 activity, 
of	 cell	 growth,	 induction of differentiation	 and whereas	 hTR	 gene	 expression	 in	 cells	 is	 independent	
stimulation	 of	 apoptosis	 (3).	 The	 exact mechanisms	 of  	 the  	activity  of  	 this  enzyme  (8).  Scientists  	seek  for  
via	 which	 HDACi	 reduce	 tumor	 growth	 are	 still	 anti‐cancer	agents	that	specifically	target	cancer 	cells	
unclear,  	 but  a  factor  that  is  suppressed  by  	 these and	 have	 fewer	 side	 effects	 on	 normal cells	 in	 this	
inhibitors	is	 the telomerase	enzyme	(4). regard, telomerase 	now 	and 	over the last 	decade has 
*Corresponding author: Jahanbakhsh	 Asadi.	 Department of Biochemistry and Biophysics, Disorder Metabolic	 Research	 Center, Golestan University	 of
Medical	Sciences,	Gorgan,	Iran. Tel:	+98‐17‐32440225;	Fax:	 +98‐17‐32421651;	 email: dr.asadi@goums.ac.ir 
	 	 	 	 	 	 	 	 	 																																																																				 	 	 	
 
  
 
 
 
	 	 	
	 	 	 	
	 	 	 	
	
	 	
	 	 	 	
	 	 	
	 	 	 	
	 	 	 	 	
	 	 	 	
	 	 	 	
	 	 	
	
	
	 	 	
	 	 	 	 	
	 	 									
	 	 	
	 	 	
	
	
	 	 	 	
	 	
	
	 	 	 	 	 	
	 	
	 	 	 	
	 	 	 	 	
	 	 	 	
	
	 	 	
	 	
	 	
	
	 	 			
	 	
	 	
	 	 	 	 	 	 	 	
	
	
	
	 	
	 	
	 	
	 	 	 	
	 	 	
	
	
	 	 	 	
	 	 	 	
	 	
	
	 	 	
	 	 	
	 	 	 	 	 													
	 	
	
	 	 	 	
	 	 	 	 	 	 	
	 	 	 	 	 	
	 	 	 	 	
	 	 	 	 	
	 	 	 	 	 	 	
	 	 	 	
	
	 	 	 	 	 	
	 	 	 	
	 	
	 	
	 							
	 	
	 	
	 	 	
	
	
	 	
	 	
	 	 	
	
	 	
	
	
	 	 	 	 	 	 		
	 	 	 	 	 	
	 	 	 	 												
	 	
	 	
	 	 	 	 	
	 	 	 	
	 	 	 	 	 	
	 	 	 	
	 	
	
	 	
         
       
        
       
          
       
      
        
        
        
       
          
        
         
         
 
   
    
      
       
           
     
     
       
 
      
        
     
       
          
         
        
 
 
      
       
       
         
      
       
       
      
        
          
      
      
       
  
 
 
 
         
           
          
        
     
       
  
    
         
      
     
     
     
         
    
        
       
          
       
         
              
                
          
          
       
  
     
      
      
     
       
       
       
      
   
       
        
  
 
      
      
       
     
      
      
        
      
  
 
       
        
      
          
      
       
        
        
   
 
     
          
  
Telomerase activity and apoptosis in cancer Vafaiyan et al
been	considered	by	many	studies	(9).	Also,	targeting	
the	process of apoptosis,	the programmed	cell	death,	
is	 an appropriate strategy for	 prevention and
treatment	of cancer.	Due to	the fact that	many	cancer	
cells	can	 inhibit	apoptosis	 in	various	ways,	 inducing	
programmed	 cell	 death	 is	 an	 important	mechanism
for	cancer	treatment (10).	Many	studies	have	shown
that inhibition	of telomerase	 can	 affect cell	 viability
by inducing	apoptosis	without	having long	periods	of
treatment	(11).	
Thus,	according	to studies on	telomerase activity
in	cancer cells	and its effect	on the proliferation and
growth	 of cancer cells,	 this study	 examined	 the
effects of VPA	on	telomerase activity	and	two	factors
affecting apoptosis: (1)	Bax	 and (2)	Bcl‐2, in	MCF‐7
breast	cancer	cell	line.
Materials and Methods
Cell culture and VPA treatment
Human	 breast	 adenocarcinoma	 Cell	 line	 (MCF‐7	 )	
(Pasteur	 Institute,	 Tehran,	 Iran) was	 maintained at			
°37	 C	in	a humidified	condition	of	95%	air	and	5% CO2
in	 Dulbecco’s	 Modified	 Eagle’s	 Medium	 (DMEM)	
supplemented with	 10% heat‐inactivated	 fetal	 bovine
serum	 (FBS),	 100	 U/ml	 penicillin	 and	 100	 μg/ml
streptomycin(Gibco,	Germany).
VPA	 (Sigma,Germnay)	 was dissolved	 in PBS to
prepare	a stock	solution	of	100	mM	and	stored	at ‐20	°C.	
Determination of cell growth and viability
The	 sensitivity	 of MCF‐7 cells	 to	 VPA	 was	
evaluated	in vitro	using	neutral	red	assay. It is based
on the ability of viable	 cells to incorporate the
supravital	dye	neutral	red in the lysosomes.	For	this
assay,	5×104 cells/ml	were	seeded	in	triplicate	wells	
of a	24‐well microtiter plate	and	cultured overnight
prior	 to treatment.	 Cells	 were	 exposed	 to various	
concentrations	 of VPA	 (0‐32	mM)	 for	 24,	 48,	 72	hr.
Untreated	samples	were	considered as	control	cells.	
The	 extent of viability	 was	 determined	 by	 the
neutral	 red	 assay.	 The	 absorbance	 of	 the	 samples	
was	 measured using	 a spectrophotometer	 at	 a	
wavelength of 450	 nm.	 Cell	 viability	was	 calculated	
as	(mean OD of treated cells/mean OD of control	or
untreated	 cells)	 ×	 100.	 Lethal	 concentrations	 (LC50)	
of VPA	were	 obtained	 from	 concentration‐response	
curves.	 One	 million	 (1×106)	 cells	 were	 grown	 after
determination	of	of LC50	values	in	25	cm2	flasks.	After	
24	hr	of incubation,	 cells	were	 treated	with various	
concentrations	of VPA (0,	2,	8	and	16	mM)	for	24,	48	
and	72	hr	and	this	treatment was	repeated	for	three
times;	Then,	cells	were trypsinized and washed with
phosphate‐buffered	 saline (PBS).	 Next,	 the viable
cells	 were	 scored	 with	 a	 hemocytometer	 based	 on
the	exclusion	of	trypan	blue.	
Measurement of telomerase activity
Based on	 the	 protocol	 of Kim	 et al,	 quantitative
measurement	 of telomerase	 activity	 was	 conducted
using	 polymerase	 chain reaction‐based	 telomeric	
repeat	 amplification	 protocol (TRAP Assay) (Telo
TAGGG telomerase	 PCR	ELISAPLUS; Roche,	 Germany)
(12).		
The	 TRAP assay	 is a two‐step process in	 which
the	 telomerase‐mediated	 elongation	 products	
subsequently	amplified by	PCR	to	allow	highly	sens it
are	
ive
detection	 of telomerase	 activity.	 According	 to	 the	
protocol,	 5	 µg of total	 protein	 of each	 sample	 as
measured by the Bradford method (Bio‐Rad Protein
Assay,	 USA), was	 added to the reaction mixture. The
° °PCR	reaction for 30	cycles (25 C	for	20 min,	94	 C	for	5	
° °min,	94	°C	for	30	sec,	50	 C	for	30	sec,	72	 C	for	90	sec,	
72	°C for 10 min)	was	performed	using	Thermal cycler.
Products of PCR (2.5 μl)	 were used for the ELISA
reaction	and	the	absorbance of each	sample was read	at	
450	nm	using	ELISA	reader	device.	
Measurement of Bax and Bcl‐2 levels
Bax	and	Bcl‐2	protein	levels	were	measured	using	
ELISA kits (Biospes,	 China),	 according	 to the
manufacturer protocol	 as	 duplicate.	 Briefly,	 treated
and	 untreated	 cells	 were	 lysed	 according	 to the
ELISA	 kit	 instruction.	 Bax and	 Bcl‐2	 protein	 from		
the	 cell	 lysate	 specifically	 bound	 to	 the	 primary	
antibody	 and were	 detected by	 Horseradish	
peroxidase (HRP)‐conjugated	 secondary	 antibody.
Then,	Bax	and	Bcl‐2	protein	levels	were	determined	
by	 measuring	 the	 absorbance	 at 450	 nm	 using a
microplate	reader.
Statistical analysis
The	normality of	data	distribution	was	measured
using	 Kolmogorov	 ‐Smirnov	 test.	 All	 data	 were	
analyzed by	One‐way	Analysis of	variance (ANOVA),	
followed	 by	 post‐hoc Tukey’s	 test.The	 relationship	
between	 telomerase activity	 and	 the	 ratio of
Bax/Bcl‐2	was	measured	by	Pearson	correlation	test.	
A	P‐value	less	than	0.05	was	considered	statistically	
significant.	 Statistical	 analysis	was	 performed	 using	
SPSS 16.	
Results
Cytotoxic effects of VPA on MCF‐7 cells
To	 determine the effects of VPA on	 MCF‐7, cells
were	 exposed to various	 concentrations of VPA			
(0‐32	 mM)	 for	 24,	 48	 and	 72	 hr.	 Assessment of cell	
viability	by	neutral	red test	showed that	with	increasing	
dose	 and treatment time,	 an increase in cytotoxic
effects	was	 observed	 and the concentrations	 of 8,	 16 
and 32	 mM	 had the	 greatest effects compared with 
control	(P<0.05). Also,	LC50	value	for	VPA inMCF‐7 cells
after	 48	 and	 72	 hr	 were about 12	 and	 7	 mM,	
respectively	(Figure	1).	
Iran J Basic Med Sci, Vol. 18, No. 7, Jul 2015 
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Vafaiyan et al Telomerase activity and apoptosis in cancer
Figure 1. Valproic	 acid	 (VPA)	 cytotoxic	 effects	 (means±SD)	 on
MCF‐7	breast	 cancer	 cells.	One‐way	ANOVA	 followed	by	post‐hoc
Tucky's test	 was	 used to	 compare	 the	 mean Cell Viability (%)
among	 different concentrations	 of	 VPA	 at	 24,	 48	 and	 72	 hr
(*P<0.05	and	**P<0.005	compared	to	the	control	for	24,	48	and	72
hr,	respectively)
After	 determination of	 LC50	 values,	 cells	 were	
treated	with selected	 concentrations	of	VPA	 (2,	 8 and
16	mM).	
The effect of VPA on telomerase activity
Telomerase activity	 was	 investigated	 at the	
concentrations	 of 0,	 2,	 8	 and 16	 mM	 at 24,	 48			
and 72 hr (Figure 2). Telomerase activity	was	reduced
by increasing concentrations of	 VPA. Maximum
reduction	of telomerase	activity was obtained at 16	mM	
VPA at	 48 hr. Thetelomerase activity	 was	 not
significantly	 different	 between	 48 and	 72 hr,	 while
there	was	significant	differences	between	24 and 48	hr
as	well as	 24 and 72 hr	 at concentrations	0,8	 and	16
mM.
The effect of VPA on the expression of Bax and Bcl‐
2 and Bax / Bcl‐2 ratio
Bax,	Bcl‐2	and	Bax	/ Bcl‐2 were measured following
24,	 48	 and	 72	 hr	 treatment	with	 different concentra‐
tions of	VPA (0, 2, 8, 16 mM). Bax	protein levels were
augmented by increasing concentrations of VPA, and
Figure 3.	The effect of different	concentrations of VPA	(means ±
SD)	at	24,	48	and	72	hr on	the	amount	of	Bax	 protein.	The amount
of	Bax protein increased significantly in 48 hr	(*P‐value<0.05	and
**P‐value<0.005)	compared	to	24 hr.	The	amount	of	Bax	protein	is
decreased	 in	 72	 hr (ᴥP‐value<0.05	 and	 ᴥᴥP‐value<0.005)
compared	 to 48	 hr.	 The	 Bax	 protein level	 was not significant
between	24	hr	and	72	hr
Figure 2.	 The effect of different concentrations	 of	 Valproic	 acid
(VPA) (means	 ± SD)	 at 24,	 48 and 72 hr	 on telomerase	 activity.
The	 level	 of	 telomerase	 activity	 significantly decreased	 at	 48	 hr	
(*P<0.05	 and	 **P<0.005)	 and	 72 hr (#P<0.05	 and	 ##P<0.005)	
compared	to	24	hr	treatment.	Telomerase	activity at	48	hr	was	not	
significantly	different	from	that	of	72	hr	treatment
maxi
mM a
mum protein	 concentration	 was obtained	 at 16	
fter 48	hr of treatment (Figure	3).	Bcl‐2	protein	
levels	decreased	with	increasing concentrations	of VPA
and the lowest	value	was obtained at	16 mM following
72 hr treatment (Figure 4). Bax /	Bcl‐2 Ratio	was also
increased with	 increasing concentrations	 of valproic	
acid and	showed	the highest	value	at 16	mM	in	48	hr	
(Figure	5).	
Figure 4.The	effect	of	different concentrations	of	Valproic	acid	(VPA)
(means	± SD) treatment for 24,	48 and72 hr	on Bcl‐2 expression.	The
amount	of	Bcl‐2	protein	significantly	decreased	after	48	hr (*P<0.05
and	**P<0.005)	and 72	hr (#P<0.05	and	##P<0.005)	compared	to 24	
hr.	The	amount	of	Bcl‐2	protein	 is also	decreased after	72	hr (ᴥP<0.05
and	ᴥᴥP<0.005)	compared	to	48	hr
Figure 5.	 The effect of different concentrations	 of	 Valproic	 acid
(VPA)	(means	± SD)	treatment	for	24,	48	and	72	hr on	Bax/Bcl‐2
ratio.	Bax/Bcl‐2 ratio increased significantly after	48 hr (*P<0.05
and	 **P<0.005)	 and	 72	 hr (#P‐value<0.05	 and	 ##P<0.005)	
compared	 to	 24	 hr.	 Bax/Bcl‐2	 ratio	 is	 also	 increased	 after	 72	 hr	
(ᴥP<0.05	and	ᴥᴥP<0.005)	compared	to	48	hr
Iran J Basic Med Sci, Vol. 18, No. 7, Jul 2015702
	 	 	 	 	 	 	 	 	 																																																																				 	 	 	
 
  
 
 
 
	
	
	
	
	
	
	
	
	
	
	
	
		
	
	
	 	 	
	
	 	 	 	 	 	
	 	
	 	 	 	
	 	 	 	 	 	
	
	
	 	 	
	 	
	
	
	 	
	 	 	 	 	 	
	
	
	 	
	 	 	
	 	
	 	
	
	
	
	 	
	
	 	 	
	 	 	 	 	
	 	 	 	
	
	
	
	
	
	 	 	 	 	
	 	 	
	
	
	
	 	 	
	
	
	 	 	
	 	 	 	 	
	
	
	
	 	
	 	 	 	
	
	 	 	
	
	 	 	 	
	 	 	 	 	
	
	
	
	 	
	
	 	 	 	
	 	 	 	 	
	 	 	 	 	 	
	 	
	
	
	
	
	
	 	 	 	 	
	 	
	
	
		
	 	 	 	 	 	 	
 
 
	 	 	 	 	 	 	
	 	 	
	 	
	  
	
	
	
	 	
	 	
	 	 	
	 	 	 	 	 	 	 	 	
	
	 	 	
	
	
	
	 	 	 	
         
        
 
      
  
        
      
   
      
        
      
 
        
          
       
       
      
         
       
      
      
     
  
      
     
       
         
     
       
    
       
   
       
  
          
          
       
     
        
      
         
    
     
        
        
      
     
        
      
     
     
     
      
          
      
      
        
      
  
        
      
      
        
         
         
      
  
       
     
 
         
     
 
          
       
           
        
         
 
         
     
  
        
       
     
     
               
     
        
       
       
 
        
         
Telomerase activity and apoptosis in cancer Vafaiyan et al
Figure 6. Correlation	between	 telomerase	activity	and	Bax/Bcl‐2
ratio	(P=0.001)	
The relationship between telomerase activity and
Bax/Bcl‐2 ratio
The	 results	 also reported that	 there was	 a
significant correlation between reduction in telomerase
activity	and	increasing	in	Bax/Bcl‐2	ratio (P=0.001).	
Discussion
In	 this study,	 we demonstrated	 the	 cytotoxic
effects	of VPA on	MCF‐7	cells,	including	reduction	in	
cell	 viability,	 telomerase	 activity and	 altered	
expression	of Bcl‐2	family	protein	levels.	
This study	showed that	VPA	has	cytotoxic effects
on	MCF‐7	breast cancer cell lines in a	dose and time‐
dependent	manner	and	causes	a significant	decrease	
in	 cell	 survival.	 These	 results	 are	 consistent with	
previous	 studies	 showing that	 treatment	 with VPA	
resulted	 in	a significant reduction	 in	 the	 rate	of cell	
proliferation (2,	 13).	 VPA	 is	 considered	 as	 an
inhibitor	 of histone	 deacetylase	 with	 strong anti‐
proliferative	activity	 in	various	cancer	 cells	 through
multiple	 mechanisms	 including	 cell	 cycle	 arrest,
differentiation and	apoptosis	(14).	
The	 present study	 also	 described	 that with	
increasing concentrations	of	VPA,	telomerase	activity	
was declined	and	maximum	reduction of telomerase
activity in MCF‐7 cells	 was	 obtained after	 48 hr of
treatment.	 Consistent with these results,	 numerous
studies	 have	 shown	 that	 some	 inhibitors	 of histone	
deacetylase	 reduced	 telomerase	 activity	 through
suppression	of hTERT	mRNA	 levels	 (15‐17).	 In	 fact,	
HDACi‐induced	 hyperacetylation	 facilitates	 binding
of	 some	 suppressor	 to	 hTERT	 gene	 control	 region,	
resulting in	inhibition	of	telomerase	activity (4,	18).		 
In	our	study, it	was also found that	VPA resulted
in	an	 increase	 in	Bax and	reduction	of Bcl‐2	protein
levels	 in	 MCF‐7	 cells.	 In	 addition,	 Bax/Bcl‐2	 ratio	
increased	dose‐dependently	and	the	maximum	value
was	 observed	 at 16	 mM	 after	 48	 hr	 treatment.	
Several	 investigations	 showed	 that Bax/Bcl‐2	 ratio	
could	 be considered	 as an	 apoptotic index	 and	 the
balance between	Bax	and	Bcl‐2	expression	affects	the	
activation	of	mitochondrial apoptosis	pathways	(19);	
Thus, an increase in	 	 Bax/Bcl‐2	 ratio	 which	 was
observed in	 this study may	 partly reflect	 the
activation	of	mitochondrial	apoptosis	pathway	in	MCF‐
7	cells	after	treatmentwith	VPA.	In	accordance	with	our	
results,	previous	studies	showed	that	HDACi	can	induce
apoptosis	 through	 repression	 of	 apoptotic	 and
regulation of	anti‐apoptotic genes	(20).
Although following	 VPA treatment a significant
correlation	 was	 observed	 between	 reduction	 of
telomerase	 activity	 and	 increase	 in	 Bax/Bcl‐2	 ratio,	
but it is	 still	 not clear	 whether	 there	 is	 any	
association	between	changes	in	Bcl‐2	family	proteins	
and	telomerase	activity	induced	by	HDACi;	However,
some	 reports	 showed that inhibition of	 hTERT and
telomerase activity	 may facilitate the induction	 of
mitochondrial apoptosis	(21).		
Conclusion
Our	results	showed	that VPA	causes	a decrease	in	
cell	 viability	 and	 induces	 apoptosis	 by	 reducing	
telomerase	 activity	 and	 increasing Bax/	Bcl‐2	 ratio.	
Our	study	illustrated	that loss	of telomerase activity
may	be a useful	biomarker	to	evaluate the antitumor
activity of VPA in	breast cancer	cells	but still further
studies	 are	 needed.	 The	 significant correlation	 that
was	observed	between	decreased	telomerase	activity
and	 increased	 Bax/Bcl‐2	 ratio	 may	 provide	 a new	
perspective	 about	 the	 molecular	 mechanisms
involved	in	cancer	cells.	
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